Economic Damages Related to False Advertising
This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
Background
A pharmaceutical company was alleged to have misrepresented (false advertising) the medical and health benefits of over-the-counter multivitamin products and doing economic harm to consumers that purchased those products. The claimants sought to certify a class for affected consumers and initiate a class action complaint to recover class wide economic damages.
Our Analysis
Intensity was retained to determine an appropriate methodology for certifying the consumer class, and to perform economic analysis related to price premiums on products that were advertised with certain false claims. Intensity evaluated various methodologies for certifying the consumer class and proposed a methodology that was appropriate based on product sales data and consumer demographics.
Intensity also performed an analysis of damages relating to a class action complaint of unfair competition, violation of Consumer’s Legal Remedies Act, and false advertising relating to health products. Intensity estimated damages incurred based on an analysis of the economic effects of the alleged conduct on product sales and profitability.
Economic issues included class certification, price premiums, common class-wide impact, unfair competition, false advertising, and treble damages.
Latest Insights
Report | September 18, 2025
Mid-Year 2025 Update: Nazaha’s Progress in the Fight Against Corruption
As part of its ongoing mandate to enhance transparency and integrity, Saudi Arabia’s Oversight and Anti-Corruption Authority (Nazaha), has continued its efforts. For the six months to June 2025, Nazaha have conducted areas of engagement into new authorities.
Article | September 16, 2025
Justice for Players and Diarra Damages Claims
In this article, Amran Nawaz and Allan Ingraham along with Ben Cisneros and Sam Kasoulis of Morgan Sports Law discuss the JFP class action. They explore whether similar class actions could be brought by players, agents and/or clubs before the English courts, whether claims could be brought before the Court of Arbitration for Sport (CAS), and how such claims might be quantified.
News | September 16, 2025
Tamika Tremaglio Quoted in The Washington Post on WNBA CBA Negotiations
Managing Director Tamika Tremaglio was featured in The Washington Post discussing the WNBA’s collective bargaining negotiations and the players’ growing leverage to pursue innovative financial models, including equity stakes. She emphasized that today’s athletes better understand their value and may have access to unique alternatives if negotiations do not end the way players want.
See All Insights
Talk to Our Insightful Experts